NASDAQ Companies

CINCINNATI, Sept. 15, 2020 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc.(“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that […]

BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq: ZIOP), today announced the appointment […]

Also Awarded a GSA Schedule Contract to Allow Direct Sales to Federal Government Agencies and BuildingsSOLON, Ohio, Sept. 15, 2020 […]

Virtual Event Showcases CyTOF Technology and Its Use in High-Parameter Suspension Mass Cytometry and Imaging Mass CytometryLeading Academic and Pharma […]

Equillium anticipates filing a U.S. IND for Itolizumab for COVID-19 and initiating a global Phase 3 clinical study in Q4 […]

Call to be Held Tuesday, September 22nd @ 8am Eastern TimeLYON, France, September 15, 2020 — EDAP TMS SA (Nasdaq: […]

– Corporate restructuring to extend cash runway through mid-2022 and key milestones –– UBX1325 to enter clinical development in patients […]

‘EnergySource Innovation Stream with Lightbridge’ Scheduled for Streaming on  September 17 at 8:30 a.m. (Eastern Time)RESTON, Va., Sept. 15, 2020 […]

CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused […]

Abstracts to Focus on:Results from Phase 2, Open-Label, Multicenter, 2×2 Cross-Over Trial to Assess Safety and Efficacy of MS1819 in […]